Comparison of MgSO4 Versus Meperidine for Prevention of Shivering During Spinal Anesthesia

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

June 30, 2021

Study Completion Date

June 30, 2021

Conditions
Shivering
Interventions
DRUG

Magnesium sulfate

"IV Magnesium sulphate 30 mg/kg, labeled as research drug for blinding, were given in 10 minutes while patients were monitored for side effects such as hypotension, bradycardia, nausea, vomiting, itch, allergy, drowsiness, and respiratory depression."

DRUG

Meperidine

"IV Meperidine 0.5 mg/kg, labeled as research drug for blinding, were given in 10 minutes while patients were monitored for side effects such as hypotension, bradycardia, nausea, vomiting, itch, allergy, drowsiness, and respiratory depression."

Trial Locations (1)

10430

Dr. Cipto Mangunkusumo National General Hospital, Jakarta

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AnestesiaR

OTHER

NCT05110469 - Comparison of MgSO4 Versus Meperidine for Prevention of Shivering During Spinal Anesthesia | Biotech Hunter | Biotech Hunter